SEI Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

SEI Investments’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,206	Closed	-$120K	–	3838
2018 Q2	$120K	Sell	1,206 -12,253	-91%	-$1.06M	﹤0.01%	2223
2018 Q1	$1.09M	Sell	13,459 -26,318	-66%	-$2.13M	﹤0.01%	1399
2017 Q4	$3.13M	Buy	39,777 +4,849	+14%	+$403K	0.01%	1104
2017 Q3	$3.22M	Buy	+34,928	New	+$3.36M	0.01%	1057
2016 Q4	–	Sell	-5,080	Closed	-$632K	–	3148
2016 Q3	$632K	Buy	5,080 +710	+16%	+$83.8K	﹤0.01%	1402
2016 Q2	$465K	Hold	4,370	–	–	﹤0.01%	1372
2016 Q1	$500K	Buy	4,370 +1,230	+39%	+$144K	﹤0.01%	1310
2015 Q4	$447K	Sell	3,140 -640	-17%	-$73.9K	﹤0.01%	1368
2015 Q3	$340K	Buy	3,780 +700	+23%	+$73.9K	﹤0.01%	1434
2015 Q2	$355K	Buy	+3,080	New	+$324K	﹤0.01%	1276

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SEI Investments's CBPO Position: Q3 2018 in Review

SEI Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2018, closing a stake of 1,206 shares — an estimated $120K sold.

SEI Investments first reported a position in CBPO in Q2 2015 and held it in 10 quarters. The position peaked at $3.22M in Q3 2017. 82 funds tracked by Wall St. Rank hold CBPO as of Q3 2018.

SEI Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 1,206 China Biologic Products Holdings, Inc. shares in Q3 2018, an estimated $120K.
SEI Investments first reported a position in China Biologic Products Holdings, Inc. in Q2 2015 and held it in 10 quarters.
SEI Investments's China Biologic Products Holdings, Inc. position peaked at $3.22M in Q3 2017.
82 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.